1361214-47-2

Upstream product

• 99333-55-8 2-(4(S)-phenyloxazolidin-2-on-3-yl)acetyl chloride 
• 123882-32-6 2-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]acetic acid 
• 81069-39-8 (E)-ethyl 3-(3-iodophenyl)acrylate 
• 3886-69-9 (R)-1-phenyl-ethyl-amine 
• 696-41-3 m-iodobenzaldehyde 
• 1361214-41-6 C₂₅H₂₉IN₂O₃ 
• 1361214-40-5 (E)-3-(3-iodophenyl)acrylaldehyde 
• 745078-70-0 (E)-3-(3-iodophenyl)prop-2-en-1-ol 
• 1361214-44-9 (R)-tert-butyl 3-((2R,3S)-2-((E)-3-iodostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate 
• 512785-11-4 N-[(benzyloxy)carbonyl]-D-aspartic acid β-tert-butyl ester α-[(R)-α-methylbenzyl]amide 
• 512785-16-9 D-aspartic acid β-tert-butyl ester α-[(R)-α-methylbenzyl]amide 

Downstream Products

• 1354566-03-2 AVN 576 

Relevant academic research and scientific papers

Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging

SRX246 is a potent, highly selective human vasopressin V1a antagonist that crosses the blood-brain barrier in rats. CNS penetration makes SRX246 an ideal candidate for potential radiolabeling and use in visualization and characterization of the role of th